Pacer Advisors
BLUE

Pacer Advisors’s bluebird bio BLUE Stock Holding History

Pacer Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-186
Closed -$73K – 1427
2021
Q1 		$73K Sell
186
-54
-23% -$26.6K ﹤0.01% 1355
2020
Q4 		$134K Buy
240
+113
+89% +$71.6K ﹤0.01% 1310
2020
Q3 		$89K Buy
+127
New +$99K ﹤0.01% 1266
2018
Q4 		– Sell
-129
Closed -$244K – 593
2018
Q3 		$244K Buy
+129
New +$266K 0.01% 990
2018
Q1 		– Sell
-69
Closed -$160K – 1047
2017
Q4 		$160K Sell
69
-199
-74% -$404K 0.01% 924
2017
Q3 		$476K Buy
+268
New +$374K 0.04% 707

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Pacer Advisors's BLUE Position: Q2 2021 in Review

Pacer Advisors sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 186 shares — an estimated $73K sold.

Pacer Advisors first reported a position in BLUE in Q3 2017 and held it in 6 quarters. The position peaked at $476K in Q3 2017. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Pacer Advisors reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 186 bluebird bio shares in Q2 2021, an estimated $73K.
  • Pacer Advisors first reported a position in bluebird bio in Q3 2017 and held it in 6 quarters.
  • Pacer Advisors's bluebird bio position peaked at $476K in Q3 2017.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.